Oncology Corporate Profile
Maxygen uses directed evolution technologies for custom client programs to optimize biological products and processes in any sector of biotechnology. With over two decades of experience with this platform, we can facilitate the identification of novel and highly functional biosuperior proteins. Through a collaborative design process involving the client, Maxygen scientists identify functional sequence diversity to be recombined. We then generate combinatorial libraries of genes expressing candidate proteins using a process that mimics natural homologous DNA recombination. A tiered screening approach results in the identification of proteins conforming to the user-defined target product profile. Recursive rounds of evolution harness the power of combining beneficial changes to achieve significant improvements.
This company does not have any pipeline products